Does IL-17 Respond to the Disordered Lung Microbiome and Contribute to the Neutrophilic Phenotype in Asthma?

Th17/IL-17 plays an important role in host defense and hyperimmune responses against pathogenic bacteria accompanied by the recruitment of neutrophils. Th17-associated immune response is also involved in the pathogenesis of asthma, which is known as a noninfectious allergic airway disease and has be...

Full description

Saved in:
Bibliographic Details
Main Authors: Xu Yang, Yunqiu Jiang, Changzheng Wang
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2016/6470364
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849413176513265664
author Xu Yang
Yunqiu Jiang
Changzheng Wang
author_facet Xu Yang
Yunqiu Jiang
Changzheng Wang
author_sort Xu Yang
collection DOAJ
description Th17/IL-17 plays an important role in host defense and hyperimmune responses against pathogenic bacteria accompanied by the recruitment of neutrophils. Th17-associated immune response is also involved in the pathogenesis of asthma, which is known as a noninfectious allergic airway disease and has been shown to be heterogeneous. Th17-associated inflammation usually contributes to the neutrophilic phenotype, which is often characterized by greater severity, airflow obstruction, and steroid resistance. Concurrently, advanced culture-independent molecular techniques have increased our understanding of the lung microbiome and demonstrated that disorders of the lung microbiome, including changes of the total burden, diversity, and community composition, may contribute to severe, treatment-resistant neutrophilic asthma, although the precise mechanism is still unclear. Because Th17/IL-17 plays a role in bacteria-mediated immune responses and is involved in neutrophilic asthma, there may be a link between them. We review the effects of Th17/IL-17 on bacteria and asthma, showing the possibility that Th17/IL-17 may be a key player in neutrophilic asthma which may be characterized as severe or treatment-resistant by responding to the disordered lung microbiome.
format Article
id doaj-art-5cdb168b8a444223be905dc514d2ecc4
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-5cdb168b8a444223be905dc514d2ecc42025-08-20T03:34:13ZengWileyMediators of Inflammation0962-93511466-18612016-01-01201610.1155/2016/64703646470364Does IL-17 Respond to the Disordered Lung Microbiome and Contribute to the Neutrophilic Phenotype in Asthma?Xu Yang0Yunqiu Jiang1Changzheng Wang2Institute of Respiratory Diseases, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, ChinaInstitute of Respiratory Diseases, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, ChinaInstitute of Respiratory Diseases, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, ChinaTh17/IL-17 plays an important role in host defense and hyperimmune responses against pathogenic bacteria accompanied by the recruitment of neutrophils. Th17-associated immune response is also involved in the pathogenesis of asthma, which is known as a noninfectious allergic airway disease and has been shown to be heterogeneous. Th17-associated inflammation usually contributes to the neutrophilic phenotype, which is often characterized by greater severity, airflow obstruction, and steroid resistance. Concurrently, advanced culture-independent molecular techniques have increased our understanding of the lung microbiome and demonstrated that disorders of the lung microbiome, including changes of the total burden, diversity, and community composition, may contribute to severe, treatment-resistant neutrophilic asthma, although the precise mechanism is still unclear. Because Th17/IL-17 plays a role in bacteria-mediated immune responses and is involved in neutrophilic asthma, there may be a link between them. We review the effects of Th17/IL-17 on bacteria and asthma, showing the possibility that Th17/IL-17 may be a key player in neutrophilic asthma which may be characterized as severe or treatment-resistant by responding to the disordered lung microbiome.http://dx.doi.org/10.1155/2016/6470364
spellingShingle Xu Yang
Yunqiu Jiang
Changzheng Wang
Does IL-17 Respond to the Disordered Lung Microbiome and Contribute to the Neutrophilic Phenotype in Asthma?
Mediators of Inflammation
title Does IL-17 Respond to the Disordered Lung Microbiome and Contribute to the Neutrophilic Phenotype in Asthma?
title_full Does IL-17 Respond to the Disordered Lung Microbiome and Contribute to the Neutrophilic Phenotype in Asthma?
title_fullStr Does IL-17 Respond to the Disordered Lung Microbiome and Contribute to the Neutrophilic Phenotype in Asthma?
title_full_unstemmed Does IL-17 Respond to the Disordered Lung Microbiome and Contribute to the Neutrophilic Phenotype in Asthma?
title_short Does IL-17 Respond to the Disordered Lung Microbiome and Contribute to the Neutrophilic Phenotype in Asthma?
title_sort does il 17 respond to the disordered lung microbiome and contribute to the neutrophilic phenotype in asthma
url http://dx.doi.org/10.1155/2016/6470364
work_keys_str_mv AT xuyang doesil17respondtothedisorderedlungmicrobiomeandcontributetotheneutrophilicphenotypeinasthma
AT yunqiujiang doesil17respondtothedisorderedlungmicrobiomeandcontributetotheneutrophilicphenotypeinasthma
AT changzhengwang doesil17respondtothedisorderedlungmicrobiomeandcontributetotheneutrophilicphenotypeinasthma